Stem Cell's market value is the price at which a share of Stem Cell trades on a public exchange. It measures the collective expectations of Stem Cell Authority investors about its performance. Stem Cell is selling for 1.0E-4 as of the 23rd of January 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Stem Cell Authority and determine expected loss or profit from investing in Stem Cell over a given investment horizon. Check out Stem Cell Correlation, Stem Cell Volatility and Stem Cell Alpha and Beta module to complement your research on Stem Cell.
Please note, there is a significant difference between Stem Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stem Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stem Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Stem Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stem Cell's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stem Cell.
0.00
10/25/2025
No Change 0.00
0.0
In 3 months and 1 day
01/23/2026
0.00
If you would invest 0.00 in Stem Cell on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Stem Cell Authority or generate 0.0% return on investment in Stem Cell over 90 days. Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of ste... More
Stem Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stem Cell's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stem Cell Authority upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stem Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stem Cell's standard deviation. In reality, there are many statistical measures that can use Stem Cell historical prices to predict the future Stem Cell's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Stem Cell. Your research has to be compared to or analyzed against Stem Cell's peers to derive any actionable benefits. When done correctly, Stem Cell's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Stem Cell Authority.
Stem Cell Authority owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13 % return per unit of risk over the last 3 months. Stem Cell Authority exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stem Cell's Variance of 39.68, risk adjusted performance of (0.08), and Coefficient Of Variation of (793.73) to confirm the risk estimate we provide. The entity has a beta of -0.36, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Stem Cell are expected to decrease at a much lower rate. During the bear market, Stem Cell is likely to outperform the market. At this point, Stem Cell Authority has a negative expected return of -0.79%. Please make sure to validate Stem Cell's coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if Stem Cell Authority performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
Stem Cell Authority has no correlation between past and present. Overlapping area represents the amount of predictability between Stem Cell time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stem Cell Authority price movement. The serial correlation of 0.0 indicates that just 0.0% of current Stem Cell price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
-0.41
Residual Average
0.0
Price Variance
0.0
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Stem Cell financial ratios help investors to determine whether Stem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Cell security.